Literature DB >> 32450998

Is there neuroinflammation in depression? Understanding the link between the brain and the peripheral immune system in depression.

Maria Antonietta Nettis1, Carmine Maria Pariante2.   

Abstract

Compelling evidence have highlighted the role of inflammation as a possible mechanism linking environmental stress to the development of depression. In particular, the communication between the peripheral and the brain immune system might lead to brain inflammatory processes, in turn causing impaired neurogenesis and neural plasticity. As a consequence, measuring brain inflammation and its possible correlation with peripheral inflammatory processes has become the focus (and a challenge) for a number of recent studies. In this chapter we review the evidence on the link between stress, peripheral and brain inflammation and the way to measure it, through preclinical, post-mortem and clinical models of depression and in healthy humans. We describe the concept of microglial activation as a marker of neuroinflammation and the potential use of anti-inflammatory treatments in depression. The paper concludes by highlighting the unresolved questions and challenges for future studies.
© 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytokines; Depression; Immune system; Microglial activation; Neuroinflammation; Translocator protein

Mesh:

Year:  2020        PMID: 32450998     DOI: 10.1016/bs.irn.2019.12.004

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  10 in total

Review 1.  Neuroinflammation in HIV-associated depression: evidence and future perspectives.

Authors:  Arish Mudra Rakshasa-Loots; Heather C Whalley; Jaime H Vera; Simon R Cox
Journal:  Mol Psychiatry       Date:  2022-05-26       Impact factor: 13.437

Review 2.  Inflammation-driven brain and gut barrier dysfunction in stress and mood disorders.

Authors:  Ellen Doney; Alice Cadoret; Laurence Dion-Albert; Manon Lebel; Caroline Menard
Journal:  Eur J Neurosci       Date:  2021-05-17       Impact factor: 3.698

3.  Fluoxetine regulates eEF2 activity (phosphorylation) via HDAC1 inhibitory mechanism in an LPS-induced mouse model of depression.

Authors:  Weifen Li; Tahir Ali; Chengyou Zheng; Zizhen Liu; Kaiwu He; Fawad Ali Shah; Qingguo Ren; Shafiq Ur Rahman; Ningning Li; Zhi-Jian Yu; Shupeng Li
Journal:  J Neuroinflammation       Date:  2021-02-01       Impact factor: 8.322

4.  Interleukin-1 Beta in Peripheral Blood Mononuclear Cell Lysates as a Longitudinal Biomarker of Response to Antidepressants: A Pilot Study.

Authors:  Panagiotis Ferentinos; Eirini Maratou; Anastasia Antoniou; Alessandro Serretti; Nikolaos Smyrnis; Paraskevi Moutsatsou
Journal:  Front Psychiatry       Date:  2021-12-24       Impact factor: 4.157

5.  Fluoxetine inhibited the activation of A1 reactive astrocyte in a mouse model of major depressive disorder through astrocytic 5-HT2BR/β-arrestin2 pathway.

Authors:  Yinquan Fang; Xiao Ding; Yihe Zhang; Lei Cai; Yuan Ge; Kaiyang Ma; Rong Xu; Shanshan Li; Mengmeng Song; Hong Zhu; Jiaqi Liu; Jianhua Ding; Ming Lu; Gang Hu
Journal:  J Neuroinflammation       Date:  2022-01-29       Impact factor: 8.322

6.  Sleep quality, latency, and sleepiness are positively correlated with depression symptoms of Brazilians facing the pandemic-associated stressors of COVID-19.

Authors:  Ana Luíza Paula Garbuio; Talita Albertin Oliveira Carvalhal; Mariana Fatima Ribeiro Tomcix; Ivan Gustavo Masseli Dos Reis; Leonardo Henrique Dalcheco Messias
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

7.  Liquiritin Alleviates Depression-Like Behavior in CUMS Mice by Inhibiting Oxidative Stress and NLRP3 Inflammasome in Hippocampus.

Authors:  Chang Liu; Dai Yuan; Chi Zhang; Ye Tao; Ying Meng; Mengli Jin; Wu Song; Bingmei Wang; Lin Wei
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-11       Impact factor: 2.629

8.  Cerebrospinal Fluid Proteome Alterations Associated with Neuropsychiatric Symptoms in Cognitive Decline and Alzheimer's Disease.

Authors:  Magdalena Mroczek; Christopher Clark; Loïc Dayon; Gene L Bowman; Julius Popp
Journal:  Cells       Date:  2022-03-18       Impact factor: 6.600

9.  Ketamine's effect on inflammation and kynurenine pathway in depression: A systematic review.

Authors:  Emma Kopra; Valeria Mondelli; Carmine Pariante; Naghmeh Nikkheslat
Journal:  J Psychopharmacol       Date:  2021-06-26       Impact factor: 4.153

Review 10.  Is cyclooxygenase-1 involved in neuroinflammation?

Authors:  Nafiseh Ghazanfari; Aren van Waarde; Rudi A J O Dierckx; Janine Doorduin; Erik F J de Vries
Journal:  J Neurosci Res       Date:  2021-08-04       Impact factor: 4.433

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.